By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Progestins > Drospirenone > Drospirenone Dosage
Progestins
https://themeditary.com/dosage-information/drospirenone-dosage-10253.html

Drospirenone Dosage

Drug Detail:Drospirenone (Drospirenone (test))

Drug Class: Progestins

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Contraception

Take 1 tablet orally once a day at the same time each day

Start Dates:

  • When there is no current use of hormonal contraception: Day 1 start is the first day of menses
  • When switching from a combined oral contraceptive: Start on the day when the new pack of the previous combined oral contraceptive would have started
  • When switching from a transdermal patch: Start on the day the next application would have been scheduled
  • When switching from a vaginal ring: Start on the day the next insertion would have been scheduled
  • When switching from an injection: Start on the day the next injection would have been scheduled
  • When switching from an intrauterine contraceptive: Start on the day of removal
  • When switching from an implant: Start is the day of removal

Comments:
  • Consider the possibility of ovulation and conception prior to initiation of therapy.
  • Active tablets are white, inactive tablets are green; take 1 white tablet daily for the first 24 days, then 1 green tablet during the next 4 days.
  • Tablets should be taken at about the same time each day so the interval between tablets is always 24 hours.

Use: For use by females of reproductive potential to prevent pregnancy.

Usual Pediatric Dose for Contraception

Post Pubertal Females:
Take 1 tablet orally once a day at the same time each day

Start Dates:

  • When there is no current use of hormonal contraception: Day 1 start is the first day of menses
  • When switching from a combined oral contraceptive: Start on the day when the new pack of the previous combined oral contraceptive would have started
  • When switching from a transdermal patch: Start on the day the next application would have been scheduled
  • When switching from a vaginal ring: Start on the day the next insertion would have been scheduled
  • When switching from an injection: Start on the day the next injection would have been scheduled
  • When switching from an intrauterine contraceptive: Start on the day of removal
  • When switching from an implant: Start is the day of removal

Comments:
  • Consider the possibility of ovulation and conception prior to initiation of therapy.
  • Active tablets are white, inactive tablets are green; take 1 white tablet daily for the first 24 days, then 1 green tablet during the next 4 days.
  • Tablets should be taken at about the same time each day so the interval between tablets is always 24 hours.

Use: For use by females of reproductive potential to prevent pregnancy.

Renal Dose Adjustments

Contraindicated

Liver Dose Adjustments

Contraindicated

Dose Adjustments

Gastrointestinal Disturbances:

  • If nausea or vomiting occurs within 3 to 4 hours of dosing, the tablet scheduled for the following day should be taken as soon as possible (within 12 hours of usual dose, if possible)
  • If more than 2 tablets are missed, backup non-hormonal contraception should be used as described above.

Precautions

CONTRAINDICATIONS:

  • Renal Impairment
  • Adrenal insufficiency
  • Presence or history of cervical cancer or progestin sensitive cancers
  • Liver tumors, benign or malignant, or hepatic impairment
  • Undiagnosed abnormal uterine bleeding

Safety and efficacy have not been established in patients before menarche.

Consult WARNINGS section for additional precautions.

Dialysis

Contraindicated

Other Comments

Administration advice:

  • Take orally once a day at the same time every day; take pills in the order directed on the blister pack
  • Swallow whole

Missed Doses:
  • If 1 active (white) tablet is missed: Take the missed dose as soon as possible and continue taking 1 tablet once a day until packet is finished
  • If 2 or more active (white) tablets are missed: Take the last missed tablet as soon as possible and continue 1 tablet once a day until pack is finished; ADDITIONALLY, non-hormonal contraception (e.g. condoms or spermicide) should be used as back-up for intercourse within 7-days after missing tablets
  • If one or more inert (green) tablets are missed: Skip the missed dose and continue taking 1 tablet once a day until packet is finished

General:
  • Pregnancy should be considered in patients whose scheduled bleeding does not occur:
  • If patient has not been adherent (e.g. missed 1 or 2 active tablets or started later than day 1), pregnancy should be considered at the time of the first missed period and ruled out.
  • If patient has been adherent but missed 2 consecutive periods, pregnancy should be ruled out.

Monitoring:
  • Patients receiving medications that may increase serum potassium concentrations should have their serum potassium checked prior to starting treatment and during the first treatment cycle
  • Monitor potassium in patients at risk for hyperkalemia
  • Patients with diabetes may require additional glycemic monitoring
  • Observe patients with history of depression for recurrence or worsening depression

Patient advice:
  • Patients should be instructed to read the US FDA-approved patient labeling (Patient Information and Instructions for Use).
  • Patients should be informed that there are drug interactions with this drug and they should discuss all medications they are taking, including herbal supplements with their healthcare provider.
  • Patients should be instructed to seek medical help promptly if they experience signs or symptoms of high potassium levels or blood clots.
  • Patients should understand that oral contraceptive medications do not protect against HIV-infection and other sexually transmitted infections.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by